Every 10-Q that Pilgrims Pride Corporation (PPC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow PPC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PPC filings page.
Pilgrim’s Pride Corporation generated net sales of $9,158,863 (in thousands) for the six months ended June 28, 2026, compared with $9,220,374 (in thousands) a year earlier. Operating income declined to $228,506 (in thousands) and net income attributable to Pilgrim’s to $114,800 (in thousands), or $0.48 per diluted share, for a consolidated operating margin of 2.5%.
For the second quarter, net sales were $4,626,230 (in thousands), gross profit decreased 52.5% to $339,752 (in thousands), and net income attributable to Pilgrim’s was $13,377 (in thousands), versus $355,520 (in thousands) in the prior-year quarter. The U.S. segment posted an operating loss of $11,112 (in thousands), while Europe and Mexico produced operating income of $60,551 (in thousands) and $16,511 (in thousands), respectively.
Cash provided by operating activities reached $471,846 (in thousands), supporting capital expenditures of $490,422 (in thousands) and a tender offer that repurchased $250.0 million of 6.25% senior notes, leaving long-term debt, net of financing costs, at $2,861,359 (in thousands). Pilgrim’s has paid $838.5 million to date to settle Broiler Antitrust Litigation opt-out cases, including $155.4 million in the first half of 2026, and recorded an $88.2 million accrual related to a Mexican tax assessment of $269.5 million, while holding $398,304 (in thousands) of cash and $1,192.2 million of available credit facility capacity.
Pilgrim’s Pride (PPC) reported steady Q3 performance with net sales of $4,759,342 and net income of $342,813, equating to diluted EPS of $1.44. Operating income was $492,608 as margins held despite higher costs. For the nine months, net sales reached $13,979,716 and net income was $994,366, or $4.17 diluted EPS.
Cash and cash equivalents declined to $612,582 from $2,040,834 at year‑end, largely due to a special cash dividend of $1,994,347 paid year‑to‑date. Operating cash flow was strong at $1,080,440, while capital expenditures totaled $441,146. Long‑term debt stood at $3,091,663, and total stockholders’ equity was $3,555,677. The company’s U.S., Europe, and Mexico operations contributed to a balanced revenue mix, with U.S. net sales of $2,836,613 in the quarter and Europe and Mexico adding $1,392,495 and $530,234, respectively.
Shares outstanding were 237,547,447 as of October 29, 2025. Other comprehensive results reflected foreign currency movements, with a quarterly net other comprehensive loss of $45,166.